EASD final program is out. Nothing on BETonMACE but one poster on apabetalone titled
"Apabetalone modulates Th1 responses in diabetes and CVD through intrinsic and extrinsic mechanisms: in vitro and in human studies"
Looking like a lock for BETonMACE full data in November, in my opinion.
BearDownAZ